FindTrial
Sign In

A Clinico Comparative study on the role of virechana karma and Vamana karma in the management of amavata.

A CLINICO - COMPARATIVE STUDY ON THE ROLE OF VIRECHANA KARMA (E?ANDA HARITAKI YOGA) WITH AND WITHOUT PRIOR VAMANA KARMA (K?TAVEDHANA SIDDHA YOGA) IN THE MANAGEMENT OF AMAVATA (RHEUMATIOD ARTHRITIS) IN TERMS OF INTERLEUKIN 6 (IL-6). - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/056946
Enrollment
40
Registered
2023-08-25
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M069- Rheumatoid arthritis, unspecified

Interventions

None listed

Sponsors

SV Ayurvedic College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients aged between 18 to 60 years and all genders. 2.Patients presenting with the signs and symptoms of Amav ?ta. 3.Patients presenting with 2010 ACR Criteria for Rheumatoid arthritis. 4.Patients who are eligible for Vamana karma. 5.Patients who are eligible for Virechana karma.

Exclusion criteria

Exclusion criteria: 1.Patients below the age of 18 and above the age of 60 years. 2.Patients with Diabetes and Hypertension. 3.Patients with Rheumatoid Arthritis (Amav ?ta) associated with other arthritic conditions such as Gouty arthritis, Osteo arthritis etc., 4.Patients associated with any other major systemic illness such as malignancies, T.B, HIV etc., 5.Dyslipidemia.

Design outcomes

Primary

MeasureTime frame
1.To evaluate the efficacy of Vamana (K?tavedan ? siddha yoga) followed by Virechana (E?anda Haritaki yoga) in the management of Amav ?ta in terms of Interleukin 6 (IL-6). 2.To evaluate the efficacy of Virechana (E?anda Haritaki yoga) in the management of Amav ?ta in terms of Interleukin 6 (IL-6). Timepoint: At baseline after completion of treatment (21th - 39th days)—

Secondary

MeasureTime frame
To evaluate the efficacy of Vamana (K?tavedan ? siddha yoga) followed by Virechana (E?anda Haritaki yoga) in the management of Amav ?ta in terms of Interleukin 6 (IL-6). To evaluate the efficacy of Virechana (E?anda Haritaki yoga) in the management of Amav ?ta in terms of Interleukin 6 (IL-6). Timepoint: At baseline, after completion of treatment(21th-39th days)—

Countries

India

Contacts

Public ContactPidugu Hema Kumar

S.V. Ayurvedic College

avinas123419@gmail.com8099959900

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026